COMP <GO>
LUNG vs SKYA // GROSS PROFIT MARGIN
Pulmonx Corporation (NASDAQ) VS. SkyAI Inc. (NASDAQ) • 15-METRIC TALLY: LUNG 6
— SKYA 2
▲ GROSS PROFIT MARGIN LEADER: LUNG
LAST: $3.17 (+25.60%) • MKT CAP: $135.9M
gross-margins
74.20%
LAST: $2.93 (-0.68%) • MKT CAP: $126.7M
gross-margins
-30.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LUNG VS. SKYA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LUNG | SKYA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 74.20% | -30.00% | +104.20 | LUNG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -24.15% | -8.67% | -15.48 | SKYA | /fcf-yield <GO> |
| Operating Margin | -59.30% | -60.00% | +0.70 | LUNG | /operating-margins <GO> |
| Net Profit Margin | -59.70% | -60.00% | +0.30 | LUNG | /net-margins <GO> |
| Revenue Growth (YoY) | 8.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 11.30 | -11.10 | SKYA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 2/9 | +4.00 | LUNG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 79.1 | 74.0 | +5.10 | LUNG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $135.9M | $126.7M | $9.2M | LUNG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LUNG REV | SKYA REV | LUNG GROSS % | SKYA GROSS % | LUNG FCF | SKYA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $90.5M | $204.1K | 74.2% | -50.0% | -$32.8M | -$11.0M |
| FY 2024 | $83.8M | $0 | 74.0% | — | -$33.0M | -$4.5M |
| FY 2023 | $68.7M | $0 | — | — | -$37.6M | -$8.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LUNG // BETA —
SKYA // BETA —